Clinical Trial Update: Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a novel cannabinoid product for endometriosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Cannabinoid product (unidentified)

Snippet

Sponsor: Mclean Hospital | Conditions: Endometriosis | Phase 2 | Status: RECRUITING